...
首页> 外文期刊>Cancer Communications >Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy
【24h】

Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy

机译:基于血浆D-二聚体和血清白蛋白水平的累积评分可预测经胸食管切除术治疗的食管鳞状细胞癌患者的生存

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Recently, studies have shown that plasma D-dimer and serum albumin are prognostic markers for esophageal cancer. The purpose of this study was to evaluate a novel prognostic scoring system—DA score (combination of preoperative plasma D-dimer and serum albumin levels)—and analyze the association between survival of patients with esophageal squamous cell carcinoma (ESCC) and their Glasgow prognostic score. In this retrospective study, preoperative biochemical markers and clinicopathologic factors in 260 ESCC patients treated with transthoracic esophagectomy were reviewed. According to receiver operating characteristic analysis, the cutoff values of D-dimer and albumin were defined as 0.5 μg/mL and 43.8 g/L, respectively. Patients with high D-dimer levels (≥0.5 μg/mL) and low albumin levels (43.8 g/L) were assigned a score of 2, those with only one of the two abnormalities were assigned a score of 1, and those with neither of the two abnormalities were assigned a score of 0. ESCC patients with a DA score of 0, 1, and 2 numbered 55, 116, and 89, respectively. Survival analysis showed that patients with a DA score of 2 had lower overall survival (OS) rates than those with DA scores of 1 and 0 (37.1% vs. 52.6% and 76.4%, P  0.001); similar findings were observed for disease-free survival (DFS) rates (32.6% vs. 44.8% and 67.3%, P  0.001). In addition, the predictive value of the DA score was also significant in patients with stages I–IIA and stages IIB–IV ESCC. Multivariate Cox regression analyses indicated that hazard ratios (HRs) for predicting OS of patients with DA scores 1 and 2 were 2.25 (P = 0.010) and 3.14 (P  0.001), respectively, compared with those with a DA score of 0, and HRs for predicting DFS of patients with DA scores of 1 and 2 were 1.86 (P = 0.023) and 2.68 (P  0.001), respectively, compared with those with a DA scores of 0. Our study suggests that preoperative DA scores are notably associated with postoperative survival of ESCC patients.
机译:最近,研究表明血浆D-二聚体和血清白蛋白是食道癌的预后标志物。这项研究的目的是评估一种新型的预后评分系统-DA评分(术前血浆D-二聚体与血清白蛋白水平的组合)-并分析食管鳞状细胞癌(ESCC)患者的生存与其格拉斯哥预后的关系得分了。在这项回顾性研究中,回顾了经胸腔镜食管切除术治疗的260例ESCC患者的术前生化指标和临床病理因素。根据接收器工作特性分析,D-二聚体和白蛋白的截断值分别定义为0.5μg/ mL和43.8g / L。高D-二聚体水平(≥0.5μg/ mL)和低白蛋白水平(<43.8 g / L)的患者获得2分,只有两种异常之一的患者获得1分,两种异常均未分配0分。ESCC DA分数分别为0、1和2的患者分别为55、116和89。生存分析表明,DA评分为2的患者的总生存率(OS)低于DA评分为1和0的患者(37.1%对52.6%和76.4%,P <0.001);无病生存率(DFS)观察到相似的结果(32.6%对比44.8%和67.3%,P <0.001)。此外,DA评分的预测值在I–IIA期和IIB–IV期ESCC患者中也很重要。多元Cox回归分析表明,与DA得分为0的患者相比,预测DA得分为1和2的患者的OS的危险比(HRs)分别为2.25(P = 0.010)和3.14(P <0.001)。与DA评分为0的患者相比,预测DA评分为1和2的患者的DFS的HR分别为1.86(P = 0.023)和2.68(P <0.001)。我们的研究表明,术前DA评分显着相关ESCC患者的术后生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号